Related Experiment Video

Updated: Jun 25, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Targeting Myc in pediatric malignancies of the central and peripheral nervous system

Michael A Grotzer1, Deborah Castelletti, Giulio Fiaschetti

  • 1Department of Oncology, University Children's Hospital Zurich, Steinwiesstrasse 75, Zurich, Switzerland. Michael.Grotzer@kispi.uzh.ch

Current Cancer Drug Targets
|March 12, 2009
PubMed

Insights

Myc proteins are often deregulated in childhood embryonal tumors, driving aggressive cancer growth. Researchers are exploring strategies to target Myc

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Myc family genes are frequently deregulated in pediatric embryonal tumors like medulloblastoma and neuroblastoma.
  • Deregulation is associated with aggressive, poorly differentiated tumor phenotypes.
  • Myc protein functions as a transcription factor regulating critical cellular processes.

Purpose of the Study:

  • To review Myc activation mechanisms in embryonal tumors.
  • To discuss current therapeutic strategies targeting Myc for cancer treatment.

Main Methods:

  • Literature review of Myc family genes in embryonal tumors.
  • Analysis of Myc protein's role in cell growth, proliferation, and apoptosis.
  • Overview of emerging Myc-targeted cancer therapies.

Main Results:

  • Myc deregulation is a common event in aggressive pediatric embryonal cancers.
  • Myc influences cell growth, proliferation, cell cycle, differentiation, apoptosis, and motility.
  • Targeting Myc's pro-proliferative or pro-apoptotic functions presents therapeutic opportunities.

Conclusions:

  • Understanding Myc activation is crucial for developing effective treatments for embryonal tumors.
  • Targeting Myc offers a promising avenue for novel cancer therapies.
  • Further research into Myc-inhibiting and Myc-activating strategies is warranted.

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...